Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
about
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif proteinRing finger protein ZIN interacts with human immunodeficiency virus type 1 VifThe human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchHEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Human Polycomb group EED protein negatively affects HIV-1 assembly and release.Protein crystals in Adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysisBaculovirus display of single chain antibody (scFv) using a novel signal peptideVif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodiesImproved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.Role of Vif in stability of the human immunodeficiency virus type 1 coreGenetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber.Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging processFunctional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.The interaction between HIV-1 Gag and APOBEC3G.High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site.The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle.Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED.Alpha-helicoidal HEAT-like Repeat Proteins (αRep) Selected as Interactors of HIV-1 Nucleocapsid Negatively Interfere with Viral Genome Packaging and Virus Maturation.
P2860
Q24291013-6B1572C0-A7BC-4E9B-85F7-3107A428B919Q24304030-5601CE1D-8FE6-466C-9ABC-841473A1E0D7Q24649552-C9BC7078-3E76-4793-B38A-166686884206Q24678970-9200580E-E922-4C82-8B01-96F03F697D69Q26746070-6FAC79AA-9324-4AF6-B4B6-B5DAED5E257EQ28293190-EF926EED-28BD-45D2-988B-51FBF64DC2EEQ28477791-5B73D0EA-43F5-4BD2-AEF1-F49E856236DEQ30440445-061696F7-7479-472D-BA1E-94E2FD33EA77Q30444754-FA1722EF-46D4-4CC1-A99B-0ACD72BE0CCAQ33358156-2838E51A-96BD-44E5-BA5D-FD07CC193AEAQ33751786-F6A61DB5-6AB8-4F03-8CCA-F84F4814649DQ33841920-13CB9704-BF34-4BCF-A45B-2D8D2F72FCCBQ33852465-50E0835F-0E05-4FBF-9BA6-0B5FDA6F88C0Q34163977-395C7B3A-EE16-42F0-AF8E-964991B37F06Q34266485-81915FE8-4B1D-4808-BCC3-85C5C954522DQ34345408-D7F8CB2E-109A-4DFE-B42D-235CCAC83CEFQ34465108-E338D731-E508-4129-8800-864FE20E043DQ34775654-608AC818-0606-4F9B-8EB6-81416050D07BQ36827236-2C510651-6917-43FF-B8CA-52936F30A667Q36889041-4106AC91-AA7A-43A6-80CF-BB2815E2B1B4Q37204634-F78487FF-999C-4912-81B0-0D8379C9B47EQ37504507-18BA2734-AEFC-4E18-BEA8-F8A6AF909910Q37583529-4CD983CC-29E3-49BE-A702-05063DF951F3Q38765818-2B087BA9-0A09-4335-AC3A-B5682376E236Q39597709-4D49CCDC-DF06-4713-B37E-C440FCF06502Q39606358-3A110588-3551-42B6-986C-3C225A8357D3Q39612144-7FFBDB35-2EB5-4AE1-BDC8-D168CD730E0CQ40478201-9593760F-0DB9-4C3C-96C1-4C47D72024E1Q40552660-2CC2E9E6-D952-486F-BB00-289CC5B9C6E0Q40599663-44980C9E-94F0-4E38-8A4A-E04CBD550BEEQ40843405-0BAB5836-F337-42BA-A176-637CA18566E7Q41878428-31AD61B6-F7C0-4D21-A038-073690F44723Q45324180-9AE77448-176F-442E-A5ED-7AFA2CB644F8
P2860
Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@ast
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@en
type
label
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@ast
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@en
prefLabel
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@ast
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@en
P2093
P1476
Interaction and co-encapsidati ...... and Vif recombinant proteins.
@en
P2093
Boulanger P
Carrière C
Courcoul M
Fournier C
Tournier J
P304
P356
10.1099/0022-1317-79-5-1069
P407
P478
79 ( Pt 5)
P577
1998-05-01T00:00:00Z